课题基金 / 基金详情

MODELING IN ANTI CANCER DRUG DVMT PRECLINICAL STUDIES THOUGH CLINICAL TRIALS

MODELING IN ANTI CANCER DRUG DVMT PRECLINICAL STUDIES THOUGH CLINICAL TRIALS
通过临床试验进行抗癌药物 DVMT 临床前研究建模
批准号:
6480881
负责人:
MERRILL J EGORIN
金额:
$15.58万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-01 至 2002-08-31

项目摘要

项目成果

MERRILL J EGORIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We extended the work described in last year's progress report by attempting to find improved predictors of arousal from an array of variables derived from non-EEG-related measurements. We examined various other respiratory-based measures for correlation to arousal. The following were calculated on an epoch-to-epoch basis and compared to the visually-scored arousal index: (1) the average value of the fuzzy-based severity index, SI; (2) the standard deviation of SI; (3) average inspired tidal volume; (4) standard deviation of tidal volume; (5) the maximum breath-to-breath change in inspiratory peak flow; and (6) the ratio of the maximum tidal volume over the minimum tidal volume. These variables were computed from our database of 13 patients with sleep-disordered breathing. The respiratory-based variable with the highest sensitivity of predicting arousal (75%) was the standard deviation of SI. The respiratory-based variable with the highest specificity in predicting arousal was the standard deviation of tidal volume (81%). However, the sensitivity associated with this variable was only 68%. Thus, the respiratory-related measure with best overall scores in both sensitivity and specificity was the standard deviation of SI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preclinical Pharmacological Studies of Antitumor & Other Therapeutic Agents
CORE--CLINICAL PHARMACOLOGY ANALYTICAL FACILITY
Preclinical Pharmacological Studies of Antitumor & Other Therapeutic Agents
Preclinical Pharmacological Studies of Antitumor & Other Therapeutic Agents
海外基金